Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Salvo

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
BMJ (Clinical Research Ed.)|August 7, 2016
Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureasPauline Bosco-Lévy, Francesco Salvo
Therapie|November 25, 2018
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetesFrancesco Salvo, Jean-Luc Faillie
JAMA Network Open|August 20, 2024
GLP-1 Receptor Agonists and Suicidality-Caution Is NeededFrancesco Salvo, Jean-Luc Faillie
Therapie|February 19, 2026
Language models in pharmacovigilance: Applications, promises and limitsFrancesco Salvo, Lelio Crupi, Clément Cholle
British Journal of Clinical Pharmacology|February 18, 2022
Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to actionEmanuel Raschi, Francesco Salvo, Charles Khouri
Drug Safety|August 20, 2018
The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting DatabaseGenaro Castillon, Francesco Salvo, Yola Moride
Lancet (London, England)|January 28, 2014
Linagliptin for elderly patients with type 2 diabetesFrancesco Salvo, Nicholas Moore, Antoine Pariente
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
Added Therapeutic Value of Medicinal Products for French and German Health Technology Assessment Organizations: A Systematic ComparisonDenis Boucaud-Maitre, Driss Berdaï, Francesco Salvo
Therapie|May 10, 2021
Time to define common European criteria for therapeutic added valueDenis Boucaud-Maitre, Francesco Salvo, Driss Berdaï
Clinical Pharmacology and Therapeutics|May 30, 2023
Interpretation of Pharmacovigilance Disproportionality AnalysesCharles Khouri, Michele Fusaroli, Francesco Salvo, et al.
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
BMJ (Clinical Research Ed.)|August 7, 2016
Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureasPauline Bosco-Lévy, Francesco Salvo
Therapie|November 25, 2018
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetesFrancesco Salvo, Jean-Luc Faillie
JAMA Network Open|August 20, 2024
GLP-1 Receptor Agonists and Suicidality-Caution Is NeededFrancesco Salvo, Jean-Luc Faillie
Therapie|February 19, 2026
Language models in pharmacovigilance: Applications, promises and limitsFrancesco Salvo, Lelio Crupi, Clément Cholle
British Journal of Clinical Pharmacology|February 18, 2022
Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to actionEmanuel Raschi, Francesco Salvo, Charles Khouri
Drug Safety|August 20, 2018
The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting DatabaseGenaro Castillon, Francesco Salvo, Yola Moride
Lancet (London, England)|January 28, 2014
Linagliptin for elderly patients with type 2 diabetesFrancesco Salvo, Nicholas Moore, Antoine Pariente
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
Added Therapeutic Value of Medicinal Products for French and German Health Technology Assessment Organizations: A Systematic ComparisonDenis Boucaud-Maitre, Driss Berdaï, Francesco Salvo
Therapie|May 10, 2021
Time to define common European criteria for therapeutic added valueDenis Boucaud-Maitre, Francesco Salvo, Driss Berdaï
Clinical Pharmacology and Therapeutics|May 30, 2023
Interpretation of Pharmacovigilance Disproportionality AnalysesCharles Khouri, Michele Fusaroli, Francesco Salvo, et al.
Pageof 20